Solana Company (HSDT) is a publicly listed digital asset treasury firm, not a diversified ETF. It originated as a medical-device business and was renamed in September 2025 after shifting its balance sheet to hold Solana's native token, SOL. Formed in partnership with Pantera Capital and Summer Capital, the company seeks to increase SOL per share through capital markets activity, token acquisitions, buybacks, and staking operations.
Its holdings are highly concentrated, with roughly 2.3 million SOL plus modest cash and stablecoin reserves. This makes HSDT one of the larger public corporate holders of the token. As a single operating company rather than a diversified fund, essentially all exposure ties to SOL, augmented by staking income. Shares have recently traded at a discount to NAV, with the treasury valued in the low-to-mid hundreds of millions against a market cap of roughly $100–140 million.
Over the last 30 days, HSDT declined approximately 36%, moving from about $2.36 down to near $1.51 per share. The decline occurred in a volatile manner, reversing earlier gains. On a three-month basis the stock is down roughly 19%, after rising from around $1.86 in mid-August to an intraday peak near $3.27 in late September before retracing.
I also checked this using Tickeron’s AI Screener to compare the stock’s moves against peers in the digital-asset space.
The primary factor was the price of SOL itself. After trading near $119 in late September, SOL eased toward roughly $100, lowering the dollar value of the treasury. Because shares trade at a discount to NAV, the token weakness produced a larger percentage drop in the equity. A $15 million direct offering priced at a 5% premium to NAV, with warrants at a 10% premium, added share count and introduced dilution considerations even as it funded further SOL purchases. Broader risk-off sentiment in digital assets added pressure.
The three-month picture reflects rotation within digital assets and evolving views on Solana exposure. The late-summer rally aligned with greater interest in Solana-linked equities and the company’s treasury expansion, including staking rewards that added tens of thousands of SOL. A strategic enterprise designation in Hong Kong further highlighted its positioning. That momentum faded as SOL pulled back and investors reassessed the appropriate discount for the shares. The concentrated structure amplifies both gains and losses relative to the underlying token.
The outlook remains closely tied to SOL’s price, staking yields, and on-chain activity, which directly shape NAV. The gap between share price and NAV also matters, as changes in the discount can drive returns separately from token moves. Future equity issuance or buybacks, regulatory developments around digital-asset treasuries, and broader macro conditions will continue to influence sentiment. Competitive positioning among other public Solana holders may affect valuation multiples as well.
In my own workflow I often turn to Tickeron’s AI Screener when evaluating high-volatility names like HSDT. The platform lets me scan for technical patterns, volatility metrics, and peer comparisons without manually reviewing dozens of charts, which helps surface context around single-asset treasury plays.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.
HSDT saw its Momentum Indicator move below the 0 level on October 29, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 80 similar instances where the indicator turned negative. In 73 of the 80 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
HSDT moved below its 50-day moving average on October 22, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HSDT crossed bearishly below the 50-day moving average on October 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HSDT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for HSDT entered a downward trend on November 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 13 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +3.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where HSDT advanced for three days, in 171 of 206 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
HSDT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 79 (best 1 - 100 worst), indicating slightly worse than average price growth. HSDT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.688) is normal, around the industry mean (2.423). P/E Ratio (0.010) is within average values for comparable stocks, (8.341). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.318). Dividend Yield (0.000) settles around the average of (0.274) among similar stocks. P/S Ratio (11.574) is also within normal values, averaging (15.906).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HSDT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a medical technology company focused on neurological wellness
Industry InvestmentManagers